Literature DB >> 14635309

Fibromyalgia, physical activity, and daily functioning: the importance of efficacy and health-related quality of life.

S N Culos-Reed1, L R Brawley.   

Abstract

OBJECTIVE: To determine whether individuals with fibromyalgia (FM) who are more physically active differ in various psychosocial characteristics (i.e., self-efficacy, health-related quality of life [HRQL]) from those who are less active, and whether those who function better on a daily basis also differ in these characteristics from their less able counterparts.
METHODS: The predominantly female sample (n = 86) consisted of individuals medically diagnosed with FM. Measures included symptom variables, physical activity frequency and intensity, daily functioning, HRQL, efficacy for physical activity, FM pain, and other FM symptoms.
RESULTS: Discriminant function analyses to predict physical activity status (P < 0.0001) and functional ability status (P = 0.03) were significant. The variables of physical activity efficacy, pain efficacy, and the physical HRQL component were the best predictors.
CONCLUSION: Support for the importance of perceived control and HRQL for engaging in higher levels of physical activity and daily functioning was demonstrated. Future research must continue to examine psychosocial factors that affect patients' functioning with FM in order to enhance their well-being.

Entities:  

Mesh:

Year:  2000        PMID: 14635309     DOI: 10.1002/1529-0131(200012)13:6<343::aid-art3>3.0.co;2-p

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  14 in total

1.  Relationship between self-efficacy and exercise duration in patients with ankylosing spondylitis.

Authors:  Hyun-Ja Lim; Hyun-Suk Lim; Myeong Soo Lee
Journal:  Clin Rheumatol       Date:  2004-08-24       Impact factor: 2.980

2.  Ischaemic heart disease-related knowledge, behaviours, and beliefs of indo-canadians and euro-canadians: implications for physical therapists.

Authors:  Giselle Rodrigues; Lyn Jongbloed; Zhenyi Li; Elizabeth Dean
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

3.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

4.  Influence of preferred versus prescribed exercise on pain in fibromyalgia.

Authors:  Lauren W Newcomb; Kelli F Koltyn; William P Morgan; Dane B Cook
Journal:  Med Sci Sports Exerc       Date:  2011-06       Impact factor: 5.411

5.  Physical activity, quality of life, and weight status in overweight children.

Authors:  Jo Ann Shoup; Michelle Gattshall; Padma Dandamudi; Paul Estabrooks
Journal:  Qual Life Res       Date:  2008-02-22       Impact factor: 4.147

6.  Effects of guided imagery on outcomes of pain, functional status, and self-efficacy in persons diagnosed with fibromyalgia.

Authors:  Victoria Menzies; Ann Gill Taylor; Cheryl Bourguignon
Journal:  J Altern Complement Med       Date:  2006 Jan-Feb       Impact factor: 2.579

7.  Analysis of the impact of fibromyalgia on quality of life: associated factors.

Authors:  Ma Del Carmen Ubago Linares; Isabel Ruiz-Pérez; Ma José Bermejo Pérez; Antonio Olry de Labry-Lima; Elisa Hernández-Torres; Juncal Plazaola-Castaño
Journal:  Clin Rheumatol       Date:  2007-10-02       Impact factor: 2.980

8.  Spiritual needs in patients suffering from fibromyalgia.

Authors:  M Offenbaecher; N Kohls; L L Toussaint; C Sigl; A Winkelmann; R Hieblinger; A Walther; A Büssing
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-20       Impact factor: 2.629

9.  Psychological control is a key modulator of fibromyalgia symptoms and comorbidities.

Authors:  Katrina Malin; Geoffrey Owen Littlejohn
Journal:  J Pain Res       Date:  2012-11-02       Impact factor: 3.133

10.  Predictors of outcome of multidisciplinary treatment in chronic widespread pain: an observational study.

Authors:  Aleid de Rooij; Marike van der Leeden; Leo D Roorda; Martijn Pm Steultjens; Joost Dekker
Journal:  BMC Musculoskelet Disord       Date:  2013-04-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.